Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients

Clinical trial NCT01010880 · COMPLETED

Trial details

NCT number: NCT01010880
Sponsor: Biokine Therapeutics Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2008-10-01
Primary completion: 2010-07-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.